HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC labeling reg extension

This article was originally published in The Tan Sheet

Executive Summary

FDA expects to respond to industry requests for a two-year extension of the OTC labeling final rule implementation date by Jan. 28, the agency states in recent letters to CHPA and CTFA. In the letters, FDA asks the trade groups to let it complete the request and refrain from soliciting further meetings on the subject. The agency met with CHPA and CTFA Jan. 4 and Jan. 11. "Because the primary implementation date for the rule is still more than 16 months away," FDA says, "we believe a two-week period to allow for completion of our response is reasonable." The trade associations requested the extension in October (1"The Tan Sheet" Oct. 11, 1999, p. 6)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133224

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel